Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
national top stories
boston blog main
boston top stories
deals
fda
m&a
national
new york blog main
san diego blog main
san diego top stories
abbvie
ac immune
achaogen
acquisition
adams street partners
alex azar
alliances
alphabet
american hpspital association
american medical association
antibiotics
atlas ventures
bacteriophage
baseline
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biopharma
bioscicience
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
car-t chimeric antigen receptor
cd39
celgene
ceo
chris lowe
What
biopharma
4
×
drug
medicine
therapeutics
administration
announced
approval
bacteria
betting
billion
bio
blueprint
business
car
celgene
cheaper
colleagues
company
deal
disease
duchenne
exited
exome
fda
fighting
foreign
gene
government
health
historic
hundreds
industry
infections
infectious
launches
lowering
medicare
medicines
melinta
observers
Language
unset
Current search:
biopharma
×
biotech
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
